Adicet Bio
ACET
#10696
Rank
HK$0.18 B
Marketcap
HK$19.28
Share price
-1.60%
Change (1 day)
327.01%
Change (1 year)

Earnings for Adicet Bio (ACET)

Earnings in 2026 (TTM): -HK$0.78 Billion

According to Adicet Bio's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$0.92 Billion, an increase over its 2024 earnings that were of -HK$0.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adicet Bio from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$0.78 Billion-15.78%
2025 -HK$0.92 Billion-0.3%
2024 -HK$0.92 Billion-17.89%
2023 -HK$1.12 Billion104.61%
2022 -HK$0.55 Billion12.53%
2021 -HK$0.49 Billion57.39%
2020 -HK$0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
HK$99.10 B-12,903.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$54.62 B-7,156.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$52.70 B-6,908.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$9.59 B-1,339.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Hawkins
HWKN
HK$0.91 B-217.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quaker Houghton
KWR
HK$1.20 B-255.53%๐Ÿ‡บ๐Ÿ‡ธ USA